Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma

Harousseau, J. L., Avet-Loiseau, H., Mary, J., Facon, T., Attal, M., Doyen, C., Hulin, C., Garderet, L., Tiab, M., Lepeu, G., Araujo, C., Caillot, D., Petillon, M., Mathiot, C., & Moreau, P. (2010). Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma. Haematologica : the hematology journal, 95, 451. https://doi.org/10.3324/haematol.2009.015917 (Original work published 2010)